Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bonavida

Showing results (231-240 of 276) with videos related to

Pageof 28
Sort By:
Prostate Cancer and Prostatic Diseases|December 24, 2002
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) for treatment of prostate cancer: first results and review of the literatureA Van Ophoven, C P Ng, B Patel, et al.
Oncology Reports|May 19, 2011
Low toxicity of inhaled interferon-gamma in four patients with lung metastasis from renal cell carcinomaY Mizutani, T Terachi, Y Kakehi, et al.
Cancer|January 28, 1999
Blocking signaling through the Gp130 receptor chain by interleukin-6 and oncostatin M inhibits PC-3 cell growth and sensitizes the tumor cells to etoposide and cisplatin-mediated cytotoxicityN Borsellino, B Bonavida, G Ciliberto, et al.
The Journal of Biological Chemistry|September 15, 1989
Internucleosomal DNA cleavage precedes diphtheria toxin-induced cytolysis. Evidence that cell lysis is not a simple consequence of translation inhibitionM P Chang, J Bramhall, S Graves, et al.
Cellular Immunology|May 15, 1982
Propagation of mouse cytotoxic clones with characteristics of natural killer (NK) cellsE Kedar, B L Ikejiri, B Sredni, et al.
Cellular Immunology|November 1, 1982
Blocking of the induction and expression of immunologically functional T lymphocytes by rat antiactivated T-cell serumR Effros, J Fan, J Hiserodt, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 1, 1997
Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugsA Demidem, T Lam, S Alas, et al.
Immunological Reviews|January 1, 1983
Molecular interactions in T-cell-mediated cytotoxicityB Bonavida, T Bradley, J Fan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1987
Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicityJ D Katz, R Mitsuyasu, M S Gottlieb, et al.
Journal of Acquired Immune Deficiency Syndromes|October 1, 1993
Prolonged asymptomatic states in HIV-seropositive persons with 50 CD4+ T-cells/mm3: preliminary psychoimmunologic findingsG F Solomon, D Benton, J O Harker, et al.
Pageof 28

Showing results (231-240 of 276) with videos related to

Sort By:
Pageof 28
Prostate Cancer and Prostatic Diseases|December 24, 2002
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) for treatment of prostate cancer: first results and review of the literatureA Van Ophoven, C P Ng, B Patel, et al.
Oncology Reports|May 19, 2011
Low toxicity of inhaled interferon-gamma in four patients with lung metastasis from renal cell carcinomaY Mizutani, T Terachi, Y Kakehi, et al.
Cancer|January 28, 1999
Blocking signaling through the Gp130 receptor chain by interleukin-6 and oncostatin M inhibits PC-3 cell growth and sensitizes the tumor cells to etoposide and cisplatin-mediated cytotoxicityN Borsellino, B Bonavida, G Ciliberto, et al.
The Journal of Biological Chemistry|September 15, 1989
Internucleosomal DNA cleavage precedes diphtheria toxin-induced cytolysis. Evidence that cell lysis is not a simple consequence of translation inhibitionM P Chang, J Bramhall, S Graves, et al.
Cellular Immunology|May 15, 1982
Propagation of mouse cytotoxic clones with characteristics of natural killer (NK) cellsE Kedar, B L Ikejiri, B Sredni, et al.
Cellular Immunology|November 1, 1982
Blocking of the induction and expression of immunologically functional T lymphocytes by rat antiactivated T-cell serumR Effros, J Fan, J Hiserodt, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 1, 1997
Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugsA Demidem, T Lam, S Alas, et al.
Immunological Reviews|January 1, 1983
Molecular interactions in T-cell-mediated cytotoxicityB Bonavida, T Bradley, J Fan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1987
Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicityJ D Katz, R Mitsuyasu, M S Gottlieb, et al.
Journal of Acquired Immune Deficiency Syndromes|October 1, 1993
Prolonged asymptomatic states in HIV-seropositive persons with 50 CD4+ T-cells/mm3: preliminary psychoimmunologic findingsG F Solomon, D Benton, J O Harker, et al.
Pageof 28